» Articles » PMID: 7426509

Prophylaxis for Mendelson's Syndrome Before Elective Caesarean Section. A Comparison of Cimetidine and Magnesium Trisilicate Mixture Regimens

Overview
Date 1980 Jul 1
PMID 7426509
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

A clinical trial was conducted in which patients undergoing elective Caesarean section received eitherrr oral cimetidine 400 mg or magnesium trisilicate mixture BPC 20 ml before anaesthesia. The pH values of gastric fluid were significantly higher and the incidence of pH less than 2.5 was significantly lower in patients who received magnesium trisilicate mixture BPC. No adverse effects were observed in newborn infants whose mothers had received cimetidine and there was no significant difference in pH values of gastric fluid from the newborn in the two groups. The findings suggest that as a means of prophylaxis for Mendelson's syndrome in patients undergoing elective Caesarean section, magnesium trisilicate mixture BPC 20 ml is more effective than a single oral dose of cimetidine 400 mg, administered in the manner described.

Citing Articles

Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section.

Griffiths J, Gyte G, Popham P, Williams K, Paranjothy S, Broughton H Cochrane Database Syst Rev. 2021; 5:CD007579.

PMID: 34002866 PMC: 8130052. DOI: 10.1002/14651858.CD007579.pub3.


Interventions at caesarean section for reducing the risk of aspiration pneumonitis.

Paranjothy S, Griffiths J, Broughton H, Gyte G, Brown H, Thomas J Cochrane Database Syst Rev. 2014; (2):CD004943.

PMID: 24497372 PMC: 10789485. DOI: 10.1002/14651858.CD004943.pub4.


Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section.

Griffiths J, Gyte G, Paranjothy S, Brown H, Broughton H, Thomas J Cochrane Database Syst Rev. 2012; (9):CD007579.

PMID: 22972112 PMC: 4204618. DOI: 10.1002/14651858.CD007579.pub2.


Interventions at caesarean section for reducing the risk of aspiration pneumonitis.

Paranjothy S, Griffiths J, Broughton H, Gyte G, Brown H, Thomas J Cochrane Database Syst Rev. 2010; (1):CD004943.

PMID: 20091567 PMC: 4063196. DOI: 10.1002/14651858.CD004943.pub3.


Prevention of acid aspiration by H2-receptor antagonists.

FEIFEL G, Finke U, Schmitz E, EISSNER H Klin Wochenschr. 1982; 60(17):1060-2.

PMID: 7132242 DOI: 10.1007/BF01716972.